• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Lionheart Acquisition Corporation II Shareholders Approve Previously Announced Business Combination with MSP Recovery

    5/18/22 3:32:00 PM ET
    $LCAP
    $LCAPU
    Get the next $LCAP alert in real time by email

    LCAP shareholders have approved the previously announced business combination at the Special Meeting held on May 18, 2022

    Transaction Expected to Close May 20, 2022

    Lionheart Acquisition Corporation II (NASDAQ:LCAPU, LCAP, LCAPW, "Lionheart" or "LCAP"))), a publicly traded special purpose acquisition company, today announced that shareholders of record as of April 18, 2022 approved the previously announced business combination (the "Business Combination") with MSP Recovery, LLC ("MSP Recovery" or "MSP") a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader.

    Six proposals were considered and voted upon by LCAP's stockholders at the special meeting, all of which were approved. The formal results of the vote will be included in a Current Report on Form 8-K to be filed by with the U.S. Securities and Exchange Commission by LCAP.

    Pursuant to the Business Combination, at the closing, MSP will combine with LCAP and the combined company's name will be MSP Recovery, Inc. Following the closing, the shares of Class A Common Stock of the combined company are anticipated to continue to be traded on Nasdaq under the symbol "MSPR" following the Closing. The combined company's public warrants are anticipated to continue to be traded on Nasdaq under the symbol "LCAPW", and the new warrants issued in connection with the previously announced and declared LCAP dividend are anticipated to commence trading on Nasdaq under the symbol "MSPRW" when issued. The business combination is expected to close on May 20, 2022.

    About MSP Recovery

    Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions, while innovating technologies to help save lives. For more information, visit: www.msprecovery.com

    About Lionheart Acquisition Corporation II

    Lionheart Acquisition Corporation II is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, visit: www.LCAP2.com.

    No Offer or Solicitation

    No offer or offering of equity interests or securities of any kind is being made, conducted or extended at this time. This communication is for informational purposes only and does not constitute or include an offer to sell, or a solicitation of an offer to purchase or subscribe for, equity interests or securities of any kind or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Any such offer or solicitation will be made only in connection with the delivery of a prospectus meeting the requirements of the Securities Act of 1933, as amended ("Securities Act"), or exemptions therefrom.

    Important Information and Where to Find It

    In connection with the Business Combination, LCAP has filed the a Form S-4 with the SEC (the "Registration Statement"), which includes a preliminary proxy statement/prospectus of LCAP. This document does not contain all the information that should be considered concerning the Business Combination and is not intended to form the basis of any investment decision or any other decision in respect of the Business Combination. The Registration Statement was declared effective by the SEC on May 2, 2022, the definitive proxy statement/prospectus was filed with the SEC on May 3, 2022 and has been mailed to the stockholders of LCAP as of April 18, 2022, the record date established for voting on the Business Combination. SECURITYHOLDERS OF LCAP ARE URGED TO READ THE REGISTRATION STATEMENT, THE DEFINITIVE PROXY STATEMENT/PROSPECTUS (INCLUDING ALL EXHIBITS AND SUPPLEMENTS THERETO) AND OTHER DOCUMENTS AND RELEVANT MATERIALS RELATING TO THE BUSINESS COMBINATION FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING ANY VOTING DECISION WITH RESPECT TO THE BUSINESS COMBINATION BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION AND THE PARTIES TO THE PROPOSED BUSINESS COMBINATION. LCAP's stockholders are able to obtain copies of such documents, without charge, at the SEC's website at www.sec.gov, or by directing a request to: Lionheart Acquisition Corporation II, 4218 NE 2nd Avenue, Miami, Florida 33137.

    INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED THEREIN.

    Participants in the Solicitation of Proxies

    This communication is not a solicitation of a proxy from any investor or securityholder. LCAP, MSP, and their respective directors, executive officers and other members of their management and employees, including Ophir Sternberg, John Ruiz and Frank Quesada, may, under SEC rules, be deemed to be participants in the solicitation of proxies of LCAP's stockholders in connection with the Business Combination. Investors and securityholders may obtain more detailed information regarding the names, affiliations and interests of LCAP's directors and executive officers in LCAP's Annual Report on Form 10-K/A filed with the SEC on April 7, 2022, as amended, the proxy statement/prospectus, other relevant materials filed with the SEC in connection with the Business Combination when they become available, and other reports filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

    Cautionary Note Regarding Forward Looking Statements

    This communication includes forward looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act") and Section 27A of the Securities Act, which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation and availability of resources and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements are often accompanied with or by words such as "expects", "plans", " projects"," forecasts"," estimates"," intends", "expects", "anticipates", "seeks", " targets", "continues", " believes", "opinion", "will", "could", "future", "growth", or "may" (or the negatives thereof) or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward looking statements include, but are not limited to, statements regarding MSP's plans, goals and objectives, forecasts, budgets or projections and any related assumptions and statements and the implied enterprise value and MSP's expectations with respect to future performance. There is no guarantee that prospects or results or the timing of events included or referred to in this communication, including the continued utilization of LifeWallet, or that it will save lives, will be achieved or that MSP will be able to implement successfully its investment strategy or achieve its investment objectives or return targets. Accordingly, we caution you against relying on forward-looking statements. Forward looking statements also are subject to a number of significant risks and uncertainties that could cause the actual results to differ materially, and potentially adversely, from those express or implied in the forward-looking statements. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of management and are not predictions of actual performance. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions, and such differences may be material. Many actual events and circumstances are inherently subject to significant business, economic and competitive uncertainties and contingencies, and are beyond the control of MSP and are difficult to predict. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Factors that may cause such differences include, but are not limited to, operating costs and future business, investment, holding and sale decisions and costs; the risks that the anticipated benefits of the launch and adoption of LifeWallet are not realized or are delayed; the risks associated with MSP's business, including, among others, MSP's ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; litigation results; the validity of the assignments of claims to MSP; a determination that MSP's claims are not reasonable, related or necessary; the failure of MSP's clients to renew their agreements with MSP (or terminate those agreements early); MSP's claims being within applicable statutes of limitations; the inability to successfully expand the scope of MSP's claims or obtain new data and claims from MSP's existing assignor base or otherwise; the limited number of MSP's assignors and the associated concentration of MSP's current and future potential revenue; internal improvements to claims and retail billing processes by MSP's clients that reduce the need for and revenue generated by MSP's products and services; healthcare spending fluctuations; programmatic changes to the scope of benefits and limitations to payment integrity initiatives that reduce the need for MSP's services; delays in implementing MSP's services to its claims; system interruptions or failures; cyber-security breaches and other disruptions that could compromise MSP's data; MSP's failure to maintain or upgrade its operational platforms; MSP's failure to innovate and develop new solutions, or the failure of those solutions to be adopted by MSP's existing and potential assignors; MSP's failure to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third party providers; changes in legislation related to healthcare programs and policies; changes in the healthcare market; negative publicity concerning healthcare data analytics and payment accuracy; competition; successfully protecting MSP's intellectual property rights; the risk that third parties may allege infringement of their intellectual property; changes in the healthcare regulatory environment and the failure to comply with applicable laws and regulations or the increased costs associated with any such compliance; failure to manage MSP's growth; the inability to attract and retain key personnel; MSP's reliance on its senior management team and key employees and the loss it could sustain if any of those employees separated from the business; the failure of vendors and providers to deliver or perform as expected, or the loss of such vendors or providers; MSP's geographic concentration; MSP's relatively limited operating history, which makes it difficult to evaluate its current or future business prospects; the impact of the ongoing COVID-19 pandemic; and the risk that MSP may not be able to develop and maintain effective internal controls. The foregoing list of factors is not exhaustive. If any of these risks materialize or MSP's assumptions prove incorrect, actual results may differ materiality from the results implied by these forward-looking statements. There may be additional risks that we do not presently know or currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. The foregoing list of factors is not exclusive. This communication speaks only as of the date indicated, and the statements, expressions, information and data included therein may change and may become stale, out-of-date or no longer applicable. We do not have, and do not undertake, any obligation to update, amend or revise this communication (or to provide new, amended or revised materials), including with respect to any forward-looking statements, whether as a result of new information, future events, changed plans or circumstances or any other reason, except as required by law. The communication should not be relied upon as representing our assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the communication, including the forward-looking statements.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220518006054/en/

    Get the next $LCAP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LCAP
    $LCAPU

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $LCAP
    $LCAPU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MSP Recovery, Inc. Announces Completion of Business Combination Between Lionheart Acquisition Corporation II and MSP Recovery, LLC.

      MSP Recovery, Inc. to Trade on Nasdaq Under the Symbol "MSPR" Starting May 24 MSP Recovery, Inc. ("MSPR"), formerly known as Lionheart Acquisition Corporation II, a Delaware corporation (NASDAQ:LCAPU, LCAP, LCAPW, "Lionheart" or "LCAP"))), today announced that it has closed the previously announced business combination (the "transaction") with MSP Recovery, LLC. ("MSP"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader. The business combination was approved by a majority of LCAP's stockholders in an extraordinary meeting on May 18, 2022. As previously announced, following the closing, LCAP's Class A Common Stock will cease trading on the Nasdaq Capital M

      5/23/22 3:50:00 PM ET
      $LCAP
      $LCAPU
    • MSP Recovery Enters Into Agreement With Mexico's SeguriTech, a Technology Integration Pioneer, to Enhance MSPR's Data Capabilities, Position MSPR for International Growth, and Expand the LifeWallet Platform Across Mexico

      MSP Recovery, LLC ("MSP" or "MSPR"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader today announced it has entered into a Data Transfer Agreement (the "Agreement") with one of the leaders in Mexican data and cybersecurity, SeguriTech, S.A. de C.V. ("SeguriTech"), positioning MSPR to expand its services internationally. On May 18, 2022, Lionheart Acquisition Corporation II (NASDAQ:LCAPU, LCAP, LCAPW, "Lionheart" or "LCAP"))), a publicly traded special purpose acquisition company, announced that shareholders of record as of April 18, 2022 approved the previously announced business combination (the "Business Combination") with MSP Recovery, LLC, a Medicare

      5/23/22 8:58:00 AM ET
      $LCAP
      $LCAPU
    • Lionheart Acquisition Corporation II Announces Clarification Regarding New Warrants and Updated Target Closing Date

      Lionheart Acquisition Corporation II (NASDAQ:LCAPU, LCAP and LCAPW))) ("Company") announces a clarification on the issuance of New Warrants, as previously announced in connection with its business combination with MSP Recovery, LLC (the "Business Combination"). Following the closing of the Business Combination (the "Closing"), which is now expected to occur on May 23, 2022, the Company's Class A Common Stock will cease trading on the Nasdaq Capital Market ("Nasdaq CM") under the symbol "LCAP" (CUSIP 53625R104), and begin trading on Nasdaq Global Market ("Nasdaq GM") under the symbol "MSPR" (CUSIP 553745100) and the Company's warrants, each to purchase one share of Class A Common Stock at $

      5/20/22 7:15:00 PM ET
      $LCAP
      $LCAPU

    $LCAP
    $LCAPU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Rapisarda Paul Howard

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      1/23/23 3:41:41 PM ET
      $LCAP
    • SEC Form 4: Ruiz John Hasan bought $12,515 worth of shares (12,500 units at $1.00), increasing direct ownership by 8% to 172,489 units

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      11/30/22 6:49:58 AM ET
      $LCAP
    • SEC Form 4: Ruiz John Hasan bought $20,120 worth of shares (19,455 units at $1.03), increasing direct ownership by 14% to 159,989 units

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      11/21/22 4:46:50 PM ET
      $LCAP

    $LCAP
    $LCAPU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Lionheart Acquisition Corp. II (Amendment)

      SC 13G/A - MSP Recovery, Inc. (0001802450) (Subject)

      1/24/23 2:38:00 PM ET
      $LCAP
    • SEC Form SC 13G/A filed by Lionheart Acquisition Corp. II (Amendment)

      SC 13G/A - MSP Recovery, Inc. (0001802450) (Subject)

      7/26/22 3:30:12 PM ET
      $LCAP
    • SEC Form SC 13G filed by Lionheart Acquisition Corp. II

      SC 13G - MSP Recovery, Inc. (0001802450) (Subject)

      7/14/22 4:15:17 PM ET
      $LCAP

    $LCAP
    $LCAPU
    Financials

    Live finance-specific insights

    See more
    • Lionheart Acquisition Corporation II Shareholders Approve Previously Announced Business Combination with MSP Recovery

      LCAP shareholders have approved the previously announced business combination at the Special Meeting held on May 18, 2022 Transaction Expected to Close May 20, 2022 Lionheart Acquisition Corporation II (NASDAQ:LCAPU, LCAP, LCAPW, "Lionheart" or "LCAP"))), a publicly traded special purpose acquisition company, today announced that shareholders of record as of April 18, 2022 approved the previously announced business combination (the "Business Combination") with MSP Recovery, LLC ("MSP Recovery" or "MSP") a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader. Six proposals were considered and voted upon by LCAP's stockholders at the special meeting, all of whi

      5/18/22 3:32:00 PM ET
      $LCAP
      $LCAPU
    • Lionheart Acquisition Corporation II Enters into Non-Binding Term Sheets for Forward Purchase Agreement and Committed Equity Facility with Cantor Fitzgerald L.P.

      Cantor may purchase up to 3.5 million shares of Lionheart Acquisition Corporation II stock before closing of the business combination with MSP Recovery, LLC Equity facility covers the purchase of up to $1 billion in shares of the combined company after closing of the business combination MSP Recovery, LLC ("MSP Recovery" or "MSP"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, and Lionheart Acquisition Corporation II, a Delaware corporation ("LCAP" or the "Company"), today announced that LCAP has entered into a non-binding term sheet with an affiliate of Cantor Fitzgerald L.P. ("Cantor") pursuant to the terms of which, upon negotiation and executi

      5/13/22 6:23:00 PM ET
      $LCAP
      $LCAPU
    • MSP Recovery Enters into $3 Billion Agreement to Sell Select Healthcare Claims Recoveries to Virage Capital Management, an Anticipated New Source of Revenue for MSP

      Transaction proceeds represent anticipated new revenue source for MSP Recovery Transaction to include assignments from healthcare insurance payors, healthcare providers and self-funded entities. MSP Recovery, LLC, ("MSP Recovery" or "MSP"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, that in July announced a planned business combination with Lionheart Acquisition Corporation II (NASDAQ:LCAPU, LCAP, LCAPW, "Lionheart" or "LCAP"))), today announced an agreement to monetize up to $3 billion of select healthcare claims recovery interests to its investment partner, Virage Capital Management LP ("Virage"). This initial agreement provides the platform

      9/30/21 4:05:00 PM ET
      $LCAP
      $LCAPU

    $LCAP
    $LCAPU
    SEC Filings

    See more
    • SEC Form S-1/A filed by Lionheart Acquisition Corp. II (Amendment)

      S-1/A - MSP Recovery, Inc. (0001802450) (Filer)

      1/24/23 5:21:36 PM ET
      $LCAP
    • SEC Form S-1/A filed by Lionheart Acquisition Corp. II (Amendment)

      S-1/A - MSP Recovery, Inc. (0001802450) (Filer)

      1/20/23 5:20:48 PM ET
      $LCAP
    • SEC Form S-1 filed by Lionheart Acquisition Corp. II

      S-1 - MSP Recovery, Inc. (0001802450) (Filer)

      1/20/23 5:23:43 PM ET
      $LCAP